Densmore Pharmaceutical International

Densmore is a Monaco-based pharmaceutical laboratory specializing in the research and development of innovative formulations in ophthalmology and gynecology. Founded in 1946, the company has established a strong reputation for its high-quality food supplements and medical devices designed to support ocular health and women's wellness. Their product portfolio includes well-known brands such as Vitreoclar for vitreous degeneration and Gametix for fertility support. In 2018, Densmore was acquired by the Havea Group, allowing it to expand its international footprint while maintaining its focus on specialized therapeutic areas. The company is recognized for its expertise in micronutrition and its commitment to providing evidence-based health solutions.